http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020218836-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2211-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3640d1aa7d8d56a3d272af5570351c94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81f703e9dcadddc44684b51ccd5483cc
publicationDate 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020218836-A1
titleOfInvention Bone-specific complex comprising bone cell transformation recombinant protein and bone-targeting molecule
abstract The present invention relates to a bone-specific complex and can solve the stability problem of a viral carrier and foreign gene expression technology by inducing overexpression of targeted inherent genes without the influx of foreign genes. The present invention allows enhanced efficiency by stably labeling a targeted object and accurately confirming whether or not application is carried out to the targeted object, and thus can efficiently be applied to the field of developing a new protein-based drug technology requiring particular cell transformation such as osteoporosis and direct transdifferentiation.
priorityDate 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014179756-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009067757-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15459053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID860
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID294562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11820211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394565
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452890228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559215
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID536911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426184277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID645682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID367218
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID642559
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30333
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17986852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18999

Total number of triples: 51.